PriceTargets.com logo

Aurora Cannabis - ACB Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: C$5.69
  • Forecasted Upside: -10.57%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
C$6.36 As of 12/3/2024 12:58 PM ET
▼ -0.14 (-2.15%)

This chart shows the closing price for ACB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aurora Cannabis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACB

Analyst Price Target is C$5.69
▼ -10.57% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Aurora Cannabis in the last 3 months. The average price target is C$5.69, with a high forecast of C$11.00 and a low forecast of C$0.80. The average price target represents a -10.57% upside from the last price of C$6.36.

This chart shows the closing price for ACB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 4 investment analysts is to hold stock in Aurora Cannabis. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
6/11/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
9/9/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/8/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/7/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/5/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/3/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/2/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/21/2024ATB CapitalLower TargetSector PerformC$12.50 ➝ C$11.00
2/27/2024Jefferies Financial GroupLower TargetHoldC$6.12 ➝ C$4.95
2/21/2024CIBCLower TargetNeutralC$6.00
2/9/2024Canaccord Genuity GroupUpgradeHold ➝ BuyC$0.80
11/21/2023Jefferies Financial GroupLower TargetHoldC$0.69 ➝ C$0.61
11/16/2023CIBCLower TargetNeutralC$0.85 ➝ C$0.80
8/29/2023CIBCLower TargetNeutralC$1.00 ➝ C$0.85
8/11/2023CowenLower TargetC$1.00 ➝ C$0.80
6/22/2023Jefferies Financial GroupLower TargetC$1.31 ➝ C$0.72
6/16/2023CIBCLower TargetC$1.75 ➝ C$1.00
6/16/2023TD SecuritiesLower TargetC$1.30 ➝ C$1.00
6/15/2023Canaccord Genuity GroupLower TargetC$1.50 ➝ C$0.80
6/15/2023ATB CapitalLower TargetC$1.80 ➝ C$1.50
2/28/2023Jefferies Financial GroupLower TargetC$1.80 ➝ C$1.31
2/13/2023CIBCLower TargetNeutralC$2.25 ➝ C$1.75
2/13/2023Stifel NicolausLower TargetC$1.45 ➝ C$1.20
2/10/2023Canaccord Genuity GroupLower TargetC$2.00 ➝ C$1.50
1/27/2023Stifel NicolausLower TargetC$1.75 ➝ C$1.45
9/28/2022Jefferies Financial GroupLower TargetC$4.10 ➝ C$1.50
9/22/2022Stifel NicolausLower TargetC$2.15 ➝ C$1.75
9/22/2022ATB CapitalUpgradeUnderperform ➝ Sector PerformC$3.00 ➝ C$4.00
9/21/2022Atb Cap MarketsUpgradeUnderperform ➝ Sector Perform
9/21/2022Canaccord Genuity GroupUpgradeSell ➝ HoldC$2.50 ➝ C$2.00
9/21/2022Piper SandlerLower TargetNeutralC$4.00
9/19/2022CIBCLower TargetNeutralC$3.75 ➝ C$2.50
7/19/2022CowenBoost TargetC$1.85 ➝ C$2.00
7/19/2022CowenBoost TargetC$1.85 ➝ C$2.00
7/5/2022CowenLower TargetC$4.00 ➝ C$1.85
7/5/2022CowenLower TargetC$4.00 ➝ C$1.85
6/6/2022Stifel NicolausUpgradeSell ➝ HoldC$2.50 ➝ C$2.15
5/16/2022CowenLower TargetC$4.00
5/16/2022CIBCLower TargetC$6.50 ➝ C$3.75
5/16/2022CowenLower TargetC$7.00 ➝ C$4.00
5/13/2022Piper SandlerLower TargetHoldC$7.00 ➝ C$4.00
5/13/2022MKM PartnersReiterated RatingHoldC$6.50 ➝ C$3.00
5/10/2022ATB CapitalLower TargetUnderperformC$5.00 ➝ C$4.00
5/2/2022Stifel NicolausLower TargetC$3.50 ➝ C$3.00
2/11/2022Canaccord Genuity GroupLower TargetC$6.00 ➝ C$5.00
2/11/2022Piper SandlerReiterated RatingHoldC$5.00 ➝ C$7.00
2/11/2022MKM PartnersReiterated RatingHoldC$6.00 ➝ C$6.50
2/11/2022CowenLower TargetNeutralC$10.00 ➝ C$7.00
2/8/2022MKM PartnersLower TargetSellC$8.00 ➝ C$6.00
2/3/2022CIBCLower TargetC$9.25 ➝ C$6.50
11/12/2021MKM PartnersBoost TargetSellC$7.00 ➝ C$8.00
11/10/2021CowenBoost TargetC$10.00
11/10/2021CIBCUpgradeUnderperform ➝ HoldC$6.50 ➝ C$9.25
10/1/2021Jefferies Financial GroupReiterated RatingHold
9/30/2021Jefferies Financial GroupLower TargetNAC$8.56 ➝ C$7.50
9/30/2021CIBCLower TargetUnderperformC$7.00 ➝ C$6.50
9/29/2021ATB CapitalLower TargetSector PerformC$7.50 ➝ C$6.00
9/28/2021Piper SandlerReiterated RatingHoldC$7.00
9/24/2021CIBCReiterated RatingUnderperformC$7.00 ➝ C$6.50
9/23/2021CIBCLower TargetNAC$8.00 ➝ C$7.00
9/20/2021MKM PartnersLower TargetSellC$9.00 ➝ C$6.00
9/3/2021Jefferies Financial GroupUpgradeHoldC$9.44 ➝ C$6.78
7/23/2021Atb Cap MarketsReiterated RatingUnderperform
5/17/2021Stifel NicolausLower TargetNAC$7.80 ➝ C$6.50
5/17/2021CIBCLower TargetUnderperformC$9.00 ➝ C$8.00
5/14/2021CowenLower TargetNAC$16.00 ➝ C$8.50
5/14/2021MKM PartnersLower TargetNAC$9.00 ➝ C$6.00
5/14/2021ATB CapitalDowngradeSector Perform ➝ UnderperformC$13.00
5/13/2021Atb Cap MarketsDowngradeSector Perform ➝ Underperform
5/11/2021CIBCLower TargetNeutral ➝ UnderperformC$15.00 ➝ C$9.00
5/11/2021Royal Bank of CanadaDowngradeUnderperform
2/24/2021Jefferies Financial GroupBoost TargetC$4.59 ➝ C$9.44
2/16/2021CIBCBoost TargetUnderperformC$18.50
2/12/2021MKM PartnersReiterated RatingSell
2/12/2021Stifel NicolausBoost TargetC$6.50 ➝ C$7.80
2/12/2021ATB CapitalBoost TargetSector PerformC$10.50 ➝ C$13.00
2/8/2021CIBCBoost TargetC$15.00 ➝ C$17.00
11/17/2020ATB CapitalUpgradeUnderperform ➝ Sector Perform
11/16/2020Atb Cap MarketsUpgradeUnderperform ➝ Sector Perform
11/16/2020Jefferies Financial GroupLower TargetUnderperformC$6.90 ➝ C$4.93
11/10/2020CIBCBoost TargetC$12.00 ➝ C$15.00
11/10/2020CowenBoost TargetC$10.00 ➝ C$16.00
11/9/2020Atb Cap MarketsDowngradeSector Perform ➝ Underperform
11/9/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral
10/28/2020Stifel NicolausLower TargetC$10.50 ➝ C$3.60
9/29/2020Jefferies Financial GroupLower TargetC$8.70 ➝ C$6.90
9/24/2020CIBCLower TargetC$20.00 ➝ C$12.00
9/23/2020ATB CapitalLower TargetC$11.30 ➝ C$10.25
9/23/2020CowenLower TargetC$11.00 ➝ C$10.00
9/23/2020MKM PartnersLower TargetC$18.00 ➝ C$9.00
9/23/2020Pi FinancialLower TargetNeutralC$12.00 ➝ C$10.00
9/9/2020Stifel NicolausLower TargetC$16.00 ➝ C$10.50
9/9/2020ATB CapitalBoost TargetC$10.40 ➝ C$11.30
8/18/2020CIBCLower TargetC$24.00 ➝ C$20.00
6/24/2020Stifel NicolausUpgradeSell ➝ HoldC$6.20 ➝ C$17.50
5/28/2020AltaCorp CapitalBoost TargetC$2.50 ➝ C$10.40
5/25/2020CIBCBoost TargetC$14.00 ➝ C$24.00
5/22/2020Jefferies Financial GroupBoost TargetUnderperformC$12.00 ➝ C$14.00
5/19/2020CIBCLower TargetC$27.00 ➝ C$14.00
5/19/2020MKM PartnersBoost TargetC$12.00 ➝ C$18.00
5/18/2020CowenLower TargetC$12.00 ➝ C$11.00
5/12/2020CowenLower TargetC$12.00
5/12/2020Eight CapitalBoost TargetC$2.00 ➝ C$11.00
5/6/2020Pi FinancialSet TargetNeutralC$2.00
4/16/2020Jefferies Financial GroupLower TargetC$1.90 ➝ C$1.00
3/16/2020MKM PartnersLower TargetC$1.75 ➝ C$1.00
2/16/2020CIBCLower TargetC$2.50 ➝ C$2.25
2/16/2020Pi FinancialSet TargetNeutralC$2.00
2/10/2020Pi FinancialDowngradeBuy ➝ NeutralC$6.00 ➝ C$2.00
2/10/2020CIBCLower TargetC$5.00 ➝ C$2.50
2/7/2020Eight CapitalDowngradeBuy ➝ NeutralC$6.00 ➝ C$2.00
2/7/2020Stifel NicolausLower TargetC$1.75 ➝ C$1.00
12/24/2019Jefferies Financial GroupDowngradeBuy ➝ HoldC$7.00 ➝ C$3.00
12/18/2019AltaCorp CapitalReiterated RatingSector Perform
12/17/2019LaurentianSet TargetBuyC$4.75
(Data available from 12/3/2019 forward)

News Sentiment Rating

0.74 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/7/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/6/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/6/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/5/2024
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/4/2024
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/4/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/3/2024
  • 4 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/3/2024

Current Sentiment

  • 4 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Aurora Cannabis logo
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
Read More

Today's Range

Now: C$6.36
Low: C$6.27
High: C$6.52

50 Day Range

MA: C$7.21
Low: C$5.83
High: C$8.46

52 Week Range

Now: C$6.36
Low: C$3.84
High: C$12.85

Volume

139,293 shs

Average Volume

1,020,476 shs

Market Capitalization

C$347.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.71

Frequently Asked Questions

What sell-side analysts currently cover shares of Aurora Cannabis?

The following Wall Street analysts have issued research reports on Aurora Cannabis in the last year: ATB Capital, Canaccord Genuity Group Inc., CIBC, and Jefferies Financial Group Inc..
View the latest analyst ratings for ACB.

What is the current price target for Aurora Cannabis?

0 Wall Street analysts have set twelve-month price targets for Aurora Cannabis in the last year. Their average twelve-month price target is C$5.69, suggesting a possible downside of 10.6%. ATB Capital has the highest price target set, predicting ACB will reach C$11.00 in the next twelve months. Canaccord Genuity Group Inc. has the lowest price target set, forecasting a price of C$0.80 for Aurora Cannabis in the next year.
View the latest price targets for ACB.

What is the current consensus analyst rating for Aurora Cannabis?

Aurora Cannabis currently has 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ACB, but not buy more shares or sell existing shares.
View the latest ratings for ACB.

What other companies compete with Aurora Cannabis?

Other companies that are similar to Aurora Cannabis include Cronos Group, Hydropothecary, Knight Therapeutics, Canopy Growth and Cipher Pharmaceuticals. Learn More about companies similar to Aurora Cannabis.

How do I contact Aurora Cannabis' investor relations team?

Aurora Cannabis' physical mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company's listed phone number is +1-604-3625207. The official website for Aurora Cannabis is auroramj.com. Learn More about contacing Aurora Cannabis investor relations.